Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$73.29
-1.2%
$72.40
$67.37
$130.14
$12.69B1.251.36 million shs2.41 million shs
CBRE Group, Inc. stock logo
CBRE
CBRE Group
$139.41
+1.0%
$127.80
$85.00
$147.75
$41.56B1.291.81 million shs2.67 million shs
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
$145.75
+0.1%
$147.49
$121.03
$184.87
$30.93B1.111.05 million shs1.43 million shs
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$35.87
+1.7%
$33.47
$24.05
$36.32
$20.17B0.483.66 million shs3.74 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
0.00%+2.64%+4.53%-20.77%-37.34%
CBRE Group, Inc. stock logo
CBRE
CBRE Group
0.00%+4.16%+11.71%+6.54%+56.45%
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
0.00%-0.21%-3.41%-1.97%-6.22%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
0.00%+2.90%+8.50%+15.23%+36.03%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
4.5697 of 5 stars
3.13.04.22.22.51.71.3
CBRE Group, Inc. stock logo
CBRE
CBRE Group
3.6126 of 5 stars
1.54.00.02.82.12.51.9
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
4.1541 of 5 stars
2.33.01.74.03.42.50.6
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
4.8965 of 5 stars
3.61.03.33.73.91.72.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
2.18
Hold$116.0058.28% Upside
CBRE Group, Inc. stock logo
CBRE
CBRE Group
2.90
Moderate Buy$150.337.83% Upside
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
2.50
Moderate Buy$159.299.29% Upside
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
3.25
Buy$47.3331.96% Upside

Current Analyst Ratings Breakdown

Latest CBRE, ARE, EXR, and RPRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/24/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
BNP Paribas Exane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$156.00
6/13/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$160.00 ➝ $162.00
6/12/2025
CBRE Group, Inc. stock logo
CBRE
CBRE Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00 ➝ $170.00
5/28/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$141.00 ➝ $153.00
5/20/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$117.00 ➝ $95.00
5/16/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$181.00 ➝ $178.00
5/16/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$51.00
5/13/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$155.00 ➝ $161.00
5/13/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $55.00
5/12/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$149.00 ➝ $166.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$3.04B4.17$8.41 per share8.71$129.29 per share0.57
CBRE Group, Inc. stock logo
CBRE
CBRE Group
$35.77B1.16$7.34 per share19.00$30.04 per share4.64
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
$3.26B9.50$7.80 per share18.69$70.10 per share2.08
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$2.26B8.91$4.20 per share8.55$17.56 per share2.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$322.95M$0.7696.437.626.184.62%0.64%0.38%7/21/2025 (Estimated)
CBRE Group, Inc. stock logo
CBRE
CBRE Group
$968M$3.2742.6319.64N/A2.74%17.37%6.41%7/29/2025 (Estimated)
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
$854.68M$4.3133.8217.483.5427.84%6.11%3.21%7/29/2025 (Estimated)
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$858.98M$1.8519.397.381.8448.23%24.71%13.87%8/6/2025 (Estimated)

Latest CBRE, ARE, EXR, and RPRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/21/2025Q2 2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.30N/AN/AN/A$748.02 millionN/A
5/8/2025Q1 2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$0.99$1.06+$0.07$0.41$724.69 million$839.00 million
4/29/2025Q1 2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
$1.96$2.00+$0.04$2.00$705.12 million$820.00 million
4/28/2025Q1 2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$2.28$2.30+$0.02$1.65$755.64 million$758.16 million
4/24/2025Q1 2025
CBRE Group, Inc. stock logo
CBRE
CBRE Group
$0.81$0.86+$0.05$0.54$8.73 billion$8.91 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
$5.287.20%N/A694.74%15 Years
CBRE Group, Inc. stock logo
CBRE
CBRE Group
N/AN/AN/AN/AN/A
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
$6.484.45%N/A150.35%1 Years
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$0.882.45%N/A47.57%5 Years

Latest CBRE, ARE, EXR, and RPRX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/2/2025
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
quarterly$1.327.64%6/30/20256/30/20257/15/2025
5/22/2025
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
quarterly$1.624.48%6/16/20256/16/20256/30/2025
4/21/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
quarterly$0.222.7%5/16/20255/16/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
0.60
0.22
0.22
CBRE Group, Inc. stock logo
CBRE
CBRE Group
0.37
1.00
1.00
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
0.85
0.33
0.33
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
0.68
1.56
1.56

Institutional Ownership

CompanyInstitutional Ownership
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
96.54%
CBRE Group, Inc. stock logo
CBRE
CBRE Group
98.41%
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
99.11%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
54.35%

Insider Ownership

CompanyInsider Ownership
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
1.08%
CBRE Group, Inc. stock logo
CBRE
CBRE Group
0.42%
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
1.36%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
18.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alexandria Real Estate Equities, Inc. stock logo
ARE
Alexandria Real Estate Equities
590172.99 million171.00 millionOptionable
CBRE Group, Inc. stock logo
CBRE
CBRE Group
115,000298.11 million296.85 millionOptionable
Extra Space Storage Inc stock logo
EXR
Extra Space Storage
8,012212.21 million209.33 millionOptionable
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
80562.24 million455.98 millionOptionable

Recent News About These Companies

RPRX Royalty Pharma plc - Seeking Alpha
Royalty Pharma plc (RPRX) Balance Sheet - Yahoo Finance
Royalty Pharma plc - Ordinary Shares - Class A RPRX Overview
RPRX - Royalty Pharma PLC Class A Chart - Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alexandria Real Estate Equities stock logo

Alexandria Real Estate Equities NYSE:ARE

$73.29 -0.92 (-1.24%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$72.59 -0.70 (-0.95%)
As of 05:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

CBRE Group stock logo

CBRE Group NYSE:CBRE

$139.41 +1.32 (+0.96%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$85.00 -54.41 (-39.03%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CBRE Group, Inc. operates as a commercial real estate services and investment company in the United States, the United Kingdom, and internationally. The Advisory Services segment offers strategic advice and execution to owners, investors, and occupiers of real estate in connection with leasing of offices, and industrial and retail space; clients fully integrated property sales services under the CBRE Capital Markets brand; clients commercial mortgage and structured financing services; originates and sells commercial mortgage loans; property management services, such as marketing, building engineering, accounting, and financial services on a contractual basis for owners of and investors in office, industrial, and retail properties; and valuation services that include market value appraisals, litigation support, discounted cash flow analyses, and feasibility studies, as well as consulting services, such as property condition reports, hotel advisory, and environmental consulting. The Global Workplace Solutions segment provides facilities management, including day-to-day management of client-occupied space, headquarters, regional offices, administrative offices, data centers and other critical facilities, manufacturing and laboratory facilities, and distribution facilities and retail space; and project management services comprising building consulting, program, and project and cost management services under the Turner & Townsend brand name. The Real Estate Investments segment offers investment management services under the CBRE Investment Management brand to pension funds, insurance companies, sovereign wealth funds, foundations, endowments, and other institutional investors; and development services, such as real estate development and investment activities under the Trammell Crow Company and Telford Homes brands to users and investors in commercial real estate, and for their own account. CBRE Group, Inc. was founded in 1906 and is headquartered in Dallas, Texas.

Extra Space Storage stock logo

Extra Space Storage NYSE:EXR

$145.75 +0.10 (+0.07%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$142.20 -3.55 (-2.44%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Extra Space Storage Inc., headquartered in Salt Lake City, Utah, is a self-administered and self-managed REIT and a member of the S&P 500. As of December 31, 2023, the Company owned and/or operated 3,714 self-storage stores in 42 states and Washington, D.C. The Company's stores comprise approximately 2.6 million units and approximately 283.0 million square feet of rentable space operating under the Extra Space, Life Storage and Storage Express brands. The Company offers customers a wide selection of conveniently located and secure storage units across the country, including boat storage, RV storage and business storage. It is the largest operator of self-storage properties in the United States.

Royalty Pharma stock logo

Royalty Pharma NASDAQ:RPRX

$35.87 +0.60 (+1.70%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$34.68 -1.19 (-3.32%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.